Physician profile
Steven D Shotts
NPI 1174529796
$11,980.60
in general payments reported to CMS, 2019-2025
31 companies · $948 in 2025
The $948 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,704 · 2020: $1,309 · 2021: $5,966 · 2022: $474 · 2023: $564 · 2024: $1,016 · 2025: $948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,527.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $6,138.29 | 2019-2021 | |
| Medical Device Business Services, INC. | $1,064.94 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $957.43 | 2019-2025 | Dupixent |
| Stryker Corporation | $936.08 | 2019-2022 | |
| Genzyme Corporation | $786.57 | 2020-2025 | |
| Medtronic, INC. | $330.55 | 2021-2025 | Propel, Ligasure |
| Abbvie INC. | $265.80 | 2023-2024 | Alphagan P, Lumigan, Vuity |
| Smith+Nephew, INC. | $200.29 | 2019-2024 | Tula |
| Glaxosmithkline, LLC. | $178.07 | 2023-2025 | Nucala |
| Integra Lifesciences Corporation | $169.37 | 2023-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Preceptis Medical, INC. | $153.33 | 2024 | Hummingbird Tympanostomy Tube System |
| Hologic Sales and Service, LLC | $144.44 | 2022 | |
| Acclarent, INC | $113.46 | 2019-2022 | |
| Kaleo, INC. | $79.18 | 2019-2021 | |
| Resmed Corp | $53.75 | 2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $52.80 | 2023-2025 | N.A. |
| Zimmer Biomet Holdings, INC. | $43.65 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $35.39 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $33.68 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $28.97 | 2025 | Neffy |
| Intersect Ent, INC. | $28.18 | 2019-2021 | |
| Itamar Medical INC | $24.18 | 2023 | Watchpatone |
| Paratek Pharmaceuticals, INC. | $22.44 | 2025 | Xhance |
| Medtronic USA, INC. | $21.35 | 2020 | |
| Arbor Pharmaceuticals, INC. | $21.10 | 2019 | |
| Merck Sharp & Dohme LLC | $20.34 | 2023 | |
| Octapharma USA, INC. | $18.36 | 2022 | |
| Hikma Pharmaceuticals USA | $16.05 | 2023 | Ryaltris |
| Aerin Medical INC. | $16.03 | 2024 | |
| Acacia Pharma INC | $13.83 | 2021 | |
| Alk-Abello, INC | $12.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Shotts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.